CSTL Q3 2020 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

Q3 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$15M+3.0% YoY

Gross Profit

$13M83.7% margin

Operating Income

-$4M-25.6% margin

Net Income

-$5M-30.2% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+19.7%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$210M

Total Liabilities

$44M

Stockholders' Equity

$167M

Cash & Equivalents

$183M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$15M	+3.0%
Gross Profit	$13M	$13M	-2.5%
Operating Income	-$4M	$4M	-188.1%
Net Income	-$5M	$6M	-178.5%